Evidence map›Paper›PMID 41322421›Full record

ArticleFrontiers in immunology2025

Single-cell atlas of the tumor immune microenvironment across syngeneic murine models.

Jia Wang, Bin Jiang, Minjuan Deng, Han Yan, Pei Zhang, Wei Jin, Zhirong Shen

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jia Wang *Translational Discovery, Research and Medicine, BeOne Medicines, Beijing, China.
Bin Jiang *Translational Discovery, Research and Medicine, BeOne Medicines, Beijing, China.
Minjuan DengTranslational Discovery, Research and Medicine, BeOne Medicines, Beijing, China.
Han YanTranslational Discovery, Research and Medicine, BeOne Medicines, Beijing, China.
Pei ZhangTranslational Discovery, Research and Medicine, BeOne Medicines, Beijing, China.
Wei JinTranslational Discovery, Research and Medicine, BeOne Medicines, Beijing, China.
Zhirong ShenTranslational Discovery, Research and Medicine, BeOne Medicines, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor immune microenvironment plays a critical role in tumor progression and responses to immunotherapy. Nevertheless, its cellular complexity and heterogeneity remain incompletely understood. In this study, we employed high-resolution single-cell RNA sequencing on CD45+ immune cells isolated from ten syngeneic murine tumor models, representing seven distinct cancer types under treatment-naïve conditions, thereby enabling a comprehensive profiling of tumor-infiltrating immune cells. We identified seven principal immune cell populations and provided an in-depth characterization of T cells, NK/innate lymphoid cells, dendritic cells, monocytes/macrophages, and neutrophils. Cross-species analyses further delineated conserved immune cell states and transcriptomic features within the T cell and monocyte/macrophage compartments that are shared across syngeneic models and human tumors. To investigate the functional relevance of the predominant monocyte/macrophage compartment and the notable presence of neutrophils in syngeneic tumors, we evaluated responses to anti-PD-1 therapy across various models and analyzed the enrichment of monocyte/macrophage subsets in tumors that responded to treatment. Furthermore, we conducted neutrophil depletion experiments using anti-Ly6G antibodies, administered both as monotherapy and in combination with PD-1 blockade. Remarkably, an interferon-stimulated gene-high (ISG

Indexed as

NeoplasmsSingle-Cell AnalysisTumor MicroenvironmentAnimalsCell Line, TumorDisease Models, AnimalFemaleHumansImmune Checkpoint InhibitorsLymphocytes, Tumor-InfiltratingMacrophagesMiceMice, Inbred C57BLMonocytesNeutrophilsTranscriptomeImmune Checkpoint Inhibitorsanti-PD-1therapyinterferon-stimulated gene-high (ISGhigh) monocyte subsetneutrophil depletionsingle-cell atlassyngeneic murine modelstumor immune microenvironment

Identifiers

PMID41322421
PMCPMC12660277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.